{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:38:35Z","timestamp":1789641515869,"version":"4.0.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:00:00Z","timestamp":1400716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ijid.2014.04.007","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T22:10:03Z","timestamp":1402438203000},"page":"145-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Mini review: Current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1"],"prefix":"10.1016","volume":"25","author":[{"given":"Guilherme","family":"Albertoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel Jo\u00e3o Batista","family":"Castelo Gir\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Schor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.04.007_bib0005","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1537-2995.2002.00183.x","article-title":"NAT screening of blood and plasma donations: evolution of technology and regulatory policy","volume":"42","author":"Tabor","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.ijid.2014.04.007_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jviromet.2010.04.027","article-title":"Development of multiplex nucleic acid sequence-based amplification for detection of human respiratory tract viruses","volume":"168","author":"Lau","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ijid.2014.04.007_bib0015","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JCM.42.4.1564-1569.2004","article-title":"Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4","volume":"42","author":"Templeton","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0020","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/trf.12190","article-title":"Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 in blood donors","volume":"53","author":"Grabarczyk","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.ijid.2014.04.007_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMoa040085","article-title":"Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing","volume":"351","author":"Stramer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.04.007_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/esm.10.02.00516-en","article-title":"Blood safety and nucleic acid testing in Europe","volume":"10","author":"Laperche","year":"2005","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2014.04.007_bib0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1423-0410.2011.01506.x","article-title":"International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009","volume":"102","author":"Roth","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.ijid.2014.04.007_bib0040","first-page":"167","article-title":"One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus","volume":"35","author":"Levi","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.ijid.2014.04.007_bib0045","doi-asserted-by":"crossref","first-page":"e19738","DOI":"10.1371\/journal.pone.0019738","article-title":"A simple, inexpensive device for nucleic acid amplification without electricity\u2014toward instrument-free molecular diagnostics in low-resource settings","volume":"6","author":"LaBarre","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.04.007_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrmicro841","article-title":"Diagnostics for the developing world","volume":"2","author":"Mabey","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00216-010-3661-4","article-title":"Development and application of lateral flow test strip technology for detection of infectious agents and chemical contaminants: a review","volume":"397","author":"Ngom","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.ijid.2014.04.007_bib0060","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro1569","article-title":"Why do we need quality-assured diagnostic tests for sexually transmitted infections?","volume":"4","author":"Peeling","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1473-3099(10)70092-X","article-title":"Accelerating worldwide syphilis screening through rapid testing: a systematic review","volume":"10","author":"Tucker","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2014.04.007_bib0080","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1556-4029.2008.00697.x","article-title":"Automated processing of forensic casework samples using robotic workstations equipped with nondisposable tips: contamination prevention","volume":"53","author":"Fr\u00e9geau","year":"2008","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.ijid.2014.04.007_bib0070","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1572-0241.2008.01825.x","article-title":"Acute hepatitis C: a systematic review","volume":"103","author":"Kamal","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2893.2007.00923.x","article-title":"Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C","volume":"1","author":"Chevaliez","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2014.04.007_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1413-8670(10)70028-3","article-title":"Signal to cut-off (S\/CO) ratio and detection of HCV genotype 1 by real-time PCR one-step method: is there any direct relationship?","volume":"14","author":"Albertoni","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2014.04.007_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0036-46652007000300008","article-title":"Primary screening of blood donors by NAT testing for HCV-RNA: development of an \u201cin-house\u201d method and results","volume":"49","author":"Wendel","year":"2007","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.ijid.2014.04.007_bib0095","first-page":"8","article-title":"Design and development of an in-house multiplex RT-PCR assay for simultaneous detection of HIV-1 and HCV in plasma samples","volume":"4","author":"Paryan","year":"2012","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1413-8670(11)70249-5","article-title":"Magnetic bead technology for viral RNA extraction from serum in blood bank screening","volume":"15","author":"Albertoni","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2014.04.007_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcv.2010.10.017","article-title":"Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests","volume":"50","author":"Glaubitz","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2009.12.017","article-title":"HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR","volume":"165","author":"De Crignis","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ijid.2014.04.007_bib0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1743-422X-11-16","article-title":"Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil","volume":"11","author":"Oliveira dos Santos","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.ijid.2014.04.007_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0971-6866.83170","article-title":"A latest and promising approach for prediction of viral load in hepatitis B virus infected patients","volume":"17","author":"Yalamanchili","year":"2011","journal-title":"Indian J Hum Genet"},{"key":"10.1016\/j.ijid.2014.04.007_bib0125","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/trf.12193","article-title":"Degenerate polymerase chain reaction strategy with DNA microarray for detection of multiple and various subtypes of virus during blood screening","volume":"53","author":"Takizawa","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.ijid.2014.04.007_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1423-0410.2012.01635.x","article-title":"Evaluation of two commercial, multi-dye, nucleic acid amplification technology tests, for HBV\/HCV\/HIV-1\/HIV-2 and B19V\/HAV, for screening blood and plasma for further manufacture","volume":"104","author":"M\u00fcller","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.ijid.2014.04.007_bib0135","unstructured":"Roche Molecular Systems, Inc. cobas\u00ae TaqScreen MPX\u00ae Test for use on the cobas\u00ae s\u00a0201 System\u00ae. Product insert: 1636, Rev. 4. Indianapolis, IN: Roche; 2009."},{"key":"10.1016\/j.ijid.2014.04.007_bib0140","unstructured":"Gen-Probe Inc. Procleix\u00ae Ultrio\u00ae Assay. Product insert: 502165, Rev. A. San Diego, CA: Gen-Probe Inc.; 2011."},{"key":"10.1016\/j.ijid.2014.04.007_bib0145","unstructured":"Gen-Probe Inc. Procleix\u00ae Ultrio\u00ae Plus Assay. Product insert: 502932, Rev. 7. San Diego, CA: Gen-Probe Inc.; 2012."},{"key":"10.1016\/j.ijid.2014.04.007_bib0150","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.2011.03283.x","article-title":"Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?","volume":"52","author":"Stramer","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.ijid.2014.04.007_bib0155","unstructured":"cobas\u00ae TaqScreen MPX\u00ae Test for use on the cobas\u00ae s201 System\u00ae. Roche; 2009. Available at: http:\/\/www.fda.gov\/downloads\/.\/UCM176443.pdf (accessed on 02\/03\/2014)."},{"key":"10.1016\/j.ijid.2014.04.007_bib0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-1119(90)90145-H","article-title":"Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions","volume":"93","author":"Longo","year":"1990","journal-title":"Gene"},{"key":"10.1016\/j.ijid.2014.04.007_bib0165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/373487a0","article-title":"The structural basis of specific base-excision repair by uracil-DNA glycosylase","volume":"373","author":"Savva","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2014.04.007_bib0170","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(95)90290-2","article-title":"Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis","volume":"80","author":"Mol","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2014.04.007_bib0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt0492-413","article-title":"Simultaneous amplification and detection of specific DNA sequences","volume":"10","author":"Higuchi","year":"1992","journal-title":"Biotechnology (N Y)"},{"key":"10.1016\/j.ijid.2014.04.007_bib0180","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","article-title":"Real time quantitative PCR","volume":"6","author":"Heid","year":"1996","journal-title":"Genome Res"},{"key":"10.1016\/j.ijid.2014.04.007_bib0185","unstructured":"cobas\u00ae TaqScreen MPX Test, v2.0 for use on the cobas\u00ae s 201 System. Rev. 1, 01\/2011. Package insert. Branchburg, NJ: Roche Molecular Systems, Inc.; 2011."},{"key":"10.1016\/j.ijid.2014.04.007_bib0190","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/hep.21413","article-title":"Characterization of HBV DNA+\/HBsAg\u2212 blood donors in Poland identified by triplex NAT","volume":"44","author":"Brojer","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2014.04.007_bib0195","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1537-2995.2008.01672.x","article-title":"A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus","volume":"48","author":"Li","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.ijid.2014.04.007_bib0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jinf.2009.06.007","article-title":"Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors","volume":"59","author":"Dettori","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2014.04.007_bib0205","unstructured":"cobas\u00ae TaqScreen MPX\u00ae Test, for use on the cobas\u00ae s201 System\u00ae, Rev. 5, 01\/2010. Package insert. Branchburg, NJ: Roche Molecular Systems, Inc.; 2010."},{"key":"10.1016\/j.ijid.2014.04.007_bib0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1537-2995.2008.01966.x","article-title":"Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24\/anti-HIV combination assays in seroconversion panels","volume":"49","author":"Assal","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.ijid.2014.04.007_bib0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jviromet.2012.10.015","article-title":"Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System","volume":"187","author":"Xiao","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ijid.2014.04.007_bib0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcv.2005.12.003","article-title":"Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA","volume":"36","author":"McCormick","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2014.04.007_bib0225","unstructured":"US Food and Drug Administration. Guidance for industry: Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry. US FDA; 2010. Available at: http:\/\/www.fda.govQBiologicsBloodVaccinesQGuidanceComplianceRegulatoryInformation\/Guidances\/default.htm (accessed on 02\/03\/2014)."},{"key":"10.1016\/j.ijid.2014.04.007_bib0230","unstructured":"US Food and Drug Administration. Guidance for industry: use of nucleic acid tests on pooled and individual samples from donors of whole blood and blood components, including source plasma, to reduce the risk of transmission of hepatitis B virus. US FDA; 2012. Available at: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm (accessed on 02\/03\/2014)."},{"key":"10.1016\/j.ijid.2014.04.007_bib0235","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/JVI.23.2.368-376.1977","article-title":"Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction","volume":"23","author":"Landers","year":"1977","journal-title":"J Virol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214015021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214015021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T21:19:04Z","timestamp":1597958344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214015021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":47,"alternative-id":["S1201971214015021"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.04.007","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mini review: Current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}